Core Insights - The presentation features the Viking team, including the CEO and CFO, discussing the current landscape in cardiometabolic obesity, highlighting its significance and the opportunities within the industry [1]. Group 1: Company Overview - Viking is actively engaging with the biopharma sector, particularly focusing on cardiometabolic obesity, which is a growing area of interest [1]. - The company is positioned to compete with and potentially partner with large-cap names in the biopharma industry [2]. Group 2: Presentation Format - The session includes a presentation followed by a Q&A segment, utilizing the Pigeonhole app for audience interaction [3].